Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identify the proteins interacting with STX17

ABSTRACT: To identify the specific proteins interacting with STX17, HEK293T cells stably expressing Flag-STX17 were lysed and immunoprecipitated with anti-Flag antibody, and eluted for Commassie blue staining and then subjected to mass spectrometric analysis.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

SUBMITTER: chongchong zhao

LAB HEAD: Yueguang Rong

PROVIDER: PXD041897 | Pride | 2023-06-24

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	GST-PSTX17-down_B6_1_3691.d.zip	Other
	GST-PSTX17-up_B5_1_3689.d.zip	Other
	MS220877-FLAG-STX17-3.raw	Raw
	MS220877-FLAG-STX17-3.xlsx	Xlsx

Items per page:

1 - 4 of 4

Similar Datasets

LncRNA-Smad7 mediates cross-talk between Nodal/TGF-β and BMP signaling to regulate cell fate determination of pluripotent and multipotent cells

Project description:LC-MS/MS combined with the ChIRP for the mESCs of WT and lncRNA-Smad7 KO

2023-03-10 | PXD036394 | Pride

Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation

Project description:Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) is a cytosolic protein kinase that regulates multiple inflammatory and cell death pathways. Serine/Threonine phosphorylation of RIPK1 is known to suppress RIPK1 kinase-mediated cell death in the contexts of inflammation, infection and embryogenesis, however, regulation by tyrosine phosphorylation has not been reported. Here, we show that non-receptor tyrosine kinases Janus kinase 1 (JAK1) and SRC are able to phosphorylate RIPK1 at Y384 (Y383 in murine RIPK1), leading to suppression of TNF-induced cell death. Mice bearing a homozygous Ripk1 mutation that prevents tyrosine phosphorylation of RIPK1 (Ripk1Y383F/Y383F), develop systemic inflammation and emergency haematopoiesis. Mechanistically, Ripk1Y383F/Y383F mutation promotes RIPK1 kinase activation and enhances TNF-induced apoptosis and necroptosis, which is partially due to impaired recruitment and activation of MAP kinase-activated protein kinase 2 (MK2). The systemic inflammation and emergency haematopoiesis in Ripk1Y383F/Y383F mice are largely alleviated by RIPK1 kinase inhibition, and prevented by genomic deletions targeted to the upstream pathway (either to Tumor necrosis factor receptor 1 or RIPK3 and Caspase8 simultaneously). In summary, our results demonstrate that tyrosine phosphorylation of RIPK1 is critical for regulating RIPK1 activity to limit cell death and inflammation.

2022-10-12 | PXD036995 | Pride

Mina53 demethylates histone 4 arginine 3 asymmetric di-methylation to regulate neural stem/progenitor cell identity

Project description:Arginine methylation of histones plays a critical role in regulating gene expression. The writers (methyltransferases) and readers of methylarginine marks are well-known, but the erasers－arginine demethylases－remain mysterious. Here we identify Myc-induced nuclear antigen 53 (Mina53), a jumonji C domain containing protein, as an arginine demethylase for removing asymmetric di-methylation at arginine 3 of histone H4 (H4R3me2a). Using photoaffinity capture method, we first identified Mina53 as an interactor of H4R3me2a. Biochemical assays in vitro and in cells characterized the arginine demethylation activity of Mina53. Molecular dynamics simulations provide further atomic-level evidence that Mina53 acts on H4R3me2a. In a transgenic mouse model, specific Mina53 deletion in neural stem/progenitor cells prevented H4R3me2a demethylation at distinct genes clusters, dysregulating genes important for neural stem/progenitor cell proliferation and differentiation, and consequently impairing the cognitive function of mice. Collectively, we identify Mina53 as a bona fide H4R3me2a eraser, expanding the understanding of epigenetic gene regulation.

2024-10-22 | PXD045247 | Pride

Single electron transfer between sulfonium and tryptophan enables site-selective photo crosslinking of methyllysine reader proteins

Project description:Reader proteins play significant roles in cell signaling from site-specific lysine methylation, but progress of new reader investigations is rather slow. Photoreactive crosslinkers enable the discovery of reader proteins, but the chemical synthesis required to optimize the placement of the photoreactive group is laborious. In addition, active intermediates such as nitrene and carbene may cause significant non-specific crosslinking. Here we report dimethylsulfonium as a methyllysine mimic that binds to specific readers and can subsequently crosslink to a conserved tryptophan inside the binding pocket through single electron transfer under UV irradiation. The crosslinking requires σ-π electron-donor-acceptor interaction between sulfonium and indole as a key step, facilitating excellent tryptophan site-selectivity and orthogonality to distinct methyllysine readers. Moreover, excited tryptophan without proximate sulfonium leads to minimal non-specific crosslinking from relaxation. This method could escalate the discovery of methyllysine readers from complex cell samples. Furthermore, this photo crosslinking concept could also be expanded to develop more types of microenvironment-dependent conjugations to site-specific tryptophan.

2024-06-30 | PXD051693 | Pride

Tau interactome mapping reveals dynamic processes associated with neurodegenerative diseases

Project description:The Tau (MAPT) protein drives neuronal dysfunction and toxicity in the brain in Alzheimer’s disease (AD) and other Tauopathies. To dissect the complexity of the Tau interactome that underlies this process we used two proteomic approaches to characterize the dynamic and multifaceted nature of Tau protein-protein interactions in human induced pluripotent stem cell (iPSC)-derived neurons. We used engineered ascorbic acid peroxidase (APEX) for spatiotemporally restricted mapping of Tau interaction proteins in combination with quantitative affinity purification mass spectrometry (AP-MS) to interrogate disease-related changes in the Tau interactome. The APEX method resolved subcellular interactions of wild-type Tau at amino acid level resolution in living neurons as well as novel activity-dependent interactions of Tau with presynaptic vesicle proteins that occurred during Tau secretion from neurons. Among the many Tau interacting proteins revealed by AP-MS, the interaction of mitochondrial proteins with wild-type Tau (TauWT) was more robust than with TauV337M or TauP301L. The mitochondrial proteins that preferentially interacted with TauWT comprised a protein module that is downregulated in multi-omics analyses of human AD brains. Mitochondrial bioenergetics were altered in TauV337M compared to TauWT human iPSC-derived neurons confirming the impact of Tau on mitochondria. These Tau interactome analyses open up novel disease-related processes as potential therapeutic targets to block Tau-mediated pathogenesis.

2022-01-11 | PXD026306 | Pride

Identification of ME2c phosphorylation site(s)

Project description:This study aims to identify the potential phosphorylation site(s) of ME2c

2023-11-26 | PXD040380 | Pride

Human SMARCA5 interactome in transgenic SMARCA5 mouse model

Project description:We hypothesize that the ISWI ATPase Smarca5 plays a role in hematopoietic stem cell development via its interaction partners, and to study the role, we used a mouse model with transgenic expression of SMARCA5 coupled with mass spectrometry analysis. The study uses transgenic SMARCA5 mouse model with conditional hypomorphic allele (lower expression on protein level compared to controls) incorporated into Rosa26 locus, transgenic allele uses endogenous Rosa26 promoter. The transgenic human SMARCA5 protein has a FLAG tag at its C-terminus, which allows specific immunoprecipitation and also differentiation from the endogenous protein (human and mouse SMARCA5 are almost identical at the protein level). To ensure the highest possible expression of the transgenic allele, we used a model that also had one endogenous Smarca5 allele deleted. Various organs (thymus, spleen, brain, kidney, liver, testes, muscle, fetal liver) were isolated from transgenic mice, lysed and then immunoprecipitated using anti-FLAG antibody. The immunoprecipitates were then analyzed using mass spectrometry to determine SMARCA5 interactomes in various tissues. Transgenic human SMARCA5 was confirmed to form all the expected complexes and capable of replacing the functions of the mouse protein. For details, see the publication of Turkova et al. 2024 in Communications Biology.

2024-06-22 | PXD049034 | Pride

PTAFR is the receptor of PRXL2A

Project description:We designed an experiment and discovered that PTAFR is the specific membrane surface receptor for PRXL2A.

2024-09-17 | PXD053615 | Pride

New protein hormone peptides were identified by mass spectrometry of mouse serum protein under fasting and refeeding state

Project description:We have discovered a protein hormone that is induced to secrete under feeding conditions. We used SDS-PAGE and silver staining to compare the differential bands of all proteins in the serum of mice under the hungry state and under the fed state, and identified several peptides of this protein under the fed state by mass spectrometry analysis.

2024-10-10 | PXD028153 | Pride

Genetic analysis of E3 ubiquitin ligases using CRISPR-Cas9 in primary T cells identifies TRAF2 and UHRF1 as regulators of HIV infection and latency reversal

Project description:During the course of HIV infection, host ubiquitination pathways are both attempting to fight off infection and are being hijacked by the virus in an attempt to optimally infect our cells. In order to more fully understand the role ubiquitination plays in HIV infection, we first defined the set of ubiquitin ligases expressed in primary CD4+ T cells using mass spectrometry. Out of the approximately 380 total ligases, we identified 116 that were expressed, and proceeded to delete them individually in primary CD4+ cells using an arrayed CRISPR/Cas9 approach.

2024-02-06 | PXD028127 | Pride